info@seagull-health.com
SeagullHealth
语言:
search
new
What are the side effects of ExtraSuperTadarise?
505
Article source: Seagull Pharmacy
Sep 19, 2025

ExtraSuperTadarise is a combined preparation, whose main ingredients include Tadalafil and Dapoxetine. It is used for the treatment of male Erectile Dysfunction (ED) and Premature Ejaculation (PE). Tadalafil is a type of PDE5 inhibitor, which improves erectile function by increasing blood flow to the penis; Dapoxetine is a short-acting selective Serotonin Reuptake Inhibitor (SSRI), used to delay the ejaculation time.

What are the side effects of ExtraSuperTadarise?

Side effects related to Tadalafil

Headache (incidence rate: 15% at a 20mg dose).

Dyspepsia (10%).

Back pain and myalgia (6%).

Nasal congestion (3%).

Facial flushing (3%).

Visual abnormalities (such as cyanopsia, incidence rate: <0.1%).

Side effects related to Dapoxetine

Nausea (8.5%-20.7%).

Dizziness (6.2%-12.1%).

Insomnia (3.1%-5.9%).

Fatigue (2.9%-6.1%).

Diarrhea (3.9%-6.8%).

Severe side effects of ExtraSuperTadarise that require vigilance

Cardiovascular risks

Fatal interaction with nitrate drugs: Concurrent use with any form of organic nitrates (such as nitroglycerin) can lead to life-threatening hypotension.

QT interval prolongation: High doses may prolong the QT interval (an average prolongation of 3.5 milliseconds at a Tadalafil dose of 100mg).

Risk of myocardial infarction: Sexual activity itself poses risks to patients with cardiovascular diseases, and this drug should not be used by cardiovascular patients who are not suitable for sexual activity.

Neurological reactions

Syncope (related to Dapoxetine, incidence rate: approximately 0.06%-0.2%)

Serotonin syndrome (especially when used in combination with other SSRIs)

Seizures (rare but require vigilance)

Other severe risks

Priapism (persistent penile erection): An erection lasting more than 4 hours requires emergency treatment to prevent permanent damage.

Sudden hearing loss: A common effect of PDE5 inhibitors, usually unilateral.

Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION): The risk is increased in patients with cardiovascular risk factors.

Precautions for taking ExtraSuperTadarise

Medication for special populations

Hepatic insufficiency: For patients with mild to moderate hepatic insufficiency, the maximum dose should not exceed 10mg per day; it is contraindicated for patients with severe hepatic insufficiency.

Renal insufficiency: For patients with moderate renal insufficiency (CrCl 30-50mL/min): the maximum dose is 10mg every 48 hours. For patients with severe renal insufficiency (CrCl <30mL/min): the maximum dose is 5mg per day.

Elderly patients: For patients aged ≥65 years, no dose adjustment is required, but careful monitoring is necessary.

Important medication instructions

Administration timing: It is recommended to take the drug 30-60 minutes before sexual activity.

Dietary effects: A high-fat meal may delay the absorption of Dapoxetine but has no effect on Tadalafil.

Alcohol restriction: Excessive alcohol consumption (≥5 units) should be avoided to prevent the enhancement of hypotensive effects.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
What Is the Therapeutic Efficacy of ExtraSuperTadarise?
ExtraSuperTadarise is a combined preparation whose main ingredients include Tadalafil and Dapoxetine. It is used for the treatment of male erectile dysfunction (ED) and premature ejaculation (PE).What...
Precautions for Administration of ExtraSuperTadarise
ExtraSuperTadarise is a combined preparation, whose main ingredients are Tadalafil and Dapoxetine. It is used for the treatment of male erectile dysfunction (ED) and premature ejaculation (PE).Precaut...
How to Use ExtraSuperTadarise
ExtraSuperTadarise is a combination preparation containing two active ingredients, Tadalafil and Dapoxetine. It is used for the treatment of male erectile dysfunction (ED) and premature ejaculation (P...
Indications of ExtraSuperTadarise
ExtraSuperTadarise is a combined preparation mainly used for the treatment of male erectile dysfunction (ED) and premature ejaculation (PE). As an enhanced formulation of Tadalafil, it combines the me...
Indications for Cabotegravir
Cabotegravir is a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI) developed by ViiV Healthcare. It was first approved in the United States in 2021. As a signifi...
Cabotegravir: Precautions and Monitoring for Medication Use
Cabotegravir is an HIV-1 integrase strand transfer inhibitor (INSTI). As the active ingredient in VOCABRIA, it must be used in combination with EDURANT (Rilpivirine) and is indicated for the short-ter...
What Is the Therapeutic Efficacy of Cabotegravir?
Cabotegravir is an HIV-1 integrase strand transfer inhibitor (INSTI). As a novel antiretroviral drug, it is used in combination with rilpivirine to provide an innovative treatment regimen for patients...
How Effective is Cabotegravir in Treatment?
Cabotegravir is an HIV-1 Integrase Strand Transfer Inhibitor (INSTI). As a novel antiretroviral drug, it is used in combination with rilpivirine to provide an innovative treatment regimen for patients...
Related Articles
Dosage and Administration, Recommended Dose of Elacestrant (Orserdu)
Elacestrant (Orserdu) is a selective estrogen receptor degrader (SERD), which provides an important treatment option for patients with estrogen receptor-positive, HER2-negative advanced or metastatic ...
What Are the Indications for Elacestrant (Orserdu)?
Elacestrant (Orserdu) is a novel endocrine therapy agent that demonstrates significant value in the treatment of advanced breast cancer with specific gene mutations. As an estrogen receptor antagonist...
What Are the Purchase Channels for Elacestrant (Orserdu)?
With the advancement of medical technology, elacestrant (Orserdu), a targeted drug for breast cancer with specific gene mutations, has brought new treatment options for patients. As the first oral sel...
Adverse Reactions of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor indicated for the treatment of patients with advanced non-small cell lung cancer harboring MET gene mutations. By precisely inhibiting the act...
What are the Precautions for Capmatinib (Tabrecta) Administration?
Capmatinib (Tabrecta) is a targeted therapy drug for MET gene mutations, demonstrating significant efficacy in the treatment of advanced malignancies such as non-small cell lung cancer.What are the Pr...
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved